MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with A

Apremilast

Apremilast 10mg/20mg/30mg tablets treatment initiation pack

No stability information

Stability notes for Apremilast 10mg/20mg/30mg tablets treatment initiation pack

There are no stability notes for this medicine.

Suppliers (9) of Apremilast 10mg/20mg/30mg tablets treatment initiation pack
Apremilast 10mg/20mg/30mg tablets treatment initiation pack (A A H Pharmaceuticals Ltd)
Apremilast 10mg/20mg/30mg tablets treatment initiation pack (Accord-UK Ltd)
Apremilast 10mg/20mg/30mg tablets treatment initiation pack (Alliance Healthcare (Distribution) Ltd)
Apremilast 10mg/20mg/30mg tablets treatment initiation pack (Amarox Ltd)
Apremilast 10mg/20mg/30mg tablets treatment initiation pack (Aristo Pharma Ltd)
Apremilast 10mg/20mg/30mg tablets treatment initiation pack (Celix Pharma Ltd)
Apremilast 10mg/20mg/30mg tablets treatment initiation pack (Genus Pharmaceuticals Ltd)
Apremilast 10mg/20mg/30mg tablets treatment initiation pack (Teva UK Ltd)
Otezla tablets treatment initiation pack (Amgen Ltd)

Apremilast 10mg tablets

No stability information

Stability notes for Apremilast 10mg tablets

There are no stability notes for this medicine.

Suppliers (9) of Apremilast 10mg tablets
Apremilast 10mg tablets (A A H Pharmaceuticals Ltd)
Apremilast 10mg tablets (Accord-UK Ltd)
Apremilast 10mg tablets (Alliance Healthcare (Distribution) Ltd)
Apremilast 10mg tablets (Amarox Ltd)
Apremilast 10mg tablets (Aristo Pharma Ltd)
Apremilast 10mg tablets (Celix Pharma Ltd)
Apremilast 10mg tablets (Genus Pharmaceuticals Ltd)
Apremilast 10mg tablets (Teva UK Ltd)
Otezla 10mg tablets (Amgen Ltd)

Apremilast 20mg tablets

No stability information

Stability notes for Apremilast 20mg tablets

There are no stability notes for this medicine.

Suppliers (9) of Apremilast 20mg tablets
Apremilast 20mg tablets (A A H Pharmaceuticals Ltd)
Apremilast 20mg tablets (Accord-UK Ltd)
Apremilast 20mg tablets (Alliance Healthcare (Distribution) Ltd)
Apremilast 20mg tablets (Amarox Ltd)
Apremilast 20mg tablets (Aristo Pharma Ltd)
Apremilast 20mg tablets (Celix Pharma Ltd)
Apremilast 20mg tablets (Genus Pharmaceuticals Ltd)
Apremilast 20mg tablets (Teva UK Ltd)
Otezla 20mg tablets (Amgen Ltd)

Apremilast 30mg tablets

No stability information

Stability notes for Apremilast 30mg tablets

There are no stability notes for this medicine.

Suppliers (11) of Apremilast 30mg tablets
Apremilast 30mg tablets (A A H Pharmaceuticals Ltd)
Apremilast 30mg tablets (Accord-UK Ltd)
Apremilast 30mg tablets (Alliance Healthcare (Distribution) Ltd)
Apremilast 30mg tablets (Amarox Ltd)
Apremilast 30mg tablets (Aristo Pharma Ltd)
Apremilast 30mg tablets (Celix Pharma Ltd)
Apremilast 30mg tablets (Genus Pharmaceuticals Ltd)
Apremilast 30mg tablets (Krka UK Ltd)
Apremilast 30mg tablets (Teva UK Ltd)
Apremilast 30mg tablets (Torrent Pharma (UK) Ltd)
Otezla 30mg tablets (Amgen Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.